{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:49:28Z","timestamp":1783655368269,"version":"3.55.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1093\/jac\/dkx110","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T11:52:29Z","timestamp":1491393149000},"page":"1893-1900","source":"Crossref","is-referenced-by-count":18,"title":["Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis"],"prefix":"10.1093","volume":"72","author":[{"given":"Tao","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinning","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjun","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"key":"key\n\t\t\t\t20170616061147_dkx110-B1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/09031936.00073611","article-title":"WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update","volume":"38","year":"2011","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B2","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/AAC.48.4.1281-1288.2004","article-title":"Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity","volume":"48","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/AAC.50.1.104-112.2006","article-title":"Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B4","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1128\/AAC.00287-09","article-title":"Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B5","first-page":"430","article-title":"Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control","volume":"81","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7861\/clinmedicine.14-3-279","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges","volume":"14","year":"2014","journal-title":"Clin Med (Lond)"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/rccm.200310-1380OC","article-title":"Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis","volume":"169","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000093486","article-title":"Susceptibility of Mycobacterium tuberculosis strains to gatifloxacin and moxifloxacin by different methods","volume":"52","year":"2006","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B9","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1128\/AAC.01049-15","article-title":"Mutations in gyrA and gyrB among fluoroquinolone- and multidrug-resistant Mycobacterium tuberculosis isolates","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkr566","article-title":"A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system","volume":"67","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B11","doi-asserted-by":"crossref","first-page":"e39754","DOI":"10.1371\/journal.pone.0039754","article-title":"New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B12","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1128\/AAC.00662-15","article-title":"Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/mdr.2006.12.7","article-title":"Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility","volume":"12","year":"2006","journal-title":"Microb Drug Resist"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B14","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1128\/AAC.00968-10","article-title":"Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00176610","article-title":"Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience","volume":"38","year":"2011","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B16","volume-title":"Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis","author":"World Health Organization","year":"2008"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jac\/dks033","article-title":"gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis","volume":"67","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B18","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1128\/AAC.00425-16","article-title":"Moxifloxacin improves treatment outcomes in patients with ofloxacin-resistant multidrug-resistant tuberculosis","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B19","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1128\/AAC.00239-08","article-title":"Role of porins for uptake of antibiotics by Mycobacterium smegmatis","volume":"52","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/emph\/eot003","article-title":"Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosis","volume":"2013","year":"2013","journal-title":"Evol Med Public Health"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B21","first-page":"292","article-title":"Evaluation of the mycobacterial interspersed repetitive units typing as a practical approach in molecular epidemiology of Mycobacterium tuberculosis","volume":"28","year":"2005","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B22","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1099\/00221287-148-10-2967","article-title":"Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv","volume":"148","year":"2002","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B23","doi-asserted-by":"crossref","first-page":"e0120470","DOI":"10.1371\/journal.pone.0120470","article-title":"Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B24","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1126\/science.1124410","article-title":"The competitive cost of antibiotic resistance in Mycobacterium tuberculosis","volume":"312","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ng.2735","article-title":"Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance","volume":"45","year":"2013","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1473-3099(16)30418-2","article-title":"Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation","volume":"17","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jac\/dku434","article-title":"Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B28","doi-asserted-by":"crossref","first-page":"e31934","DOI":"10.1371\/journal.pone.0031934","article-title":"High-resolution melting analysis for the rapid detection of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosis","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B29","doi-asserted-by":"crossref","first-page":"e12245","DOI":"10.1371\/journal.pone.0012245","article-title":"Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase","volume":"5","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B30","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1073\/pnas.1525047113","article-title":"Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis","volume":"113","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B31","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1073\/pnas.1525055113","article-title":"Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: enhancing drug activity against wild-type and resistant gyrase","volume":"113","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B32","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1128\/AAC.00541-09","article-title":"Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B33","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1128\/JCM.01916-06","article-title":"Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing","volume":"44","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/jac\/dkv360","article-title":"Specific gyrA gene mutations predict poor treatment outcome in MDR-TB","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1099\/jmm.0.046821-0","article-title":"Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin","volume":"62","year":"2013","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B36","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1128\/AAC.00944-06","article-title":"Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B37","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1038\/emi.2014.21","article-title":"Association of gyrA\/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis","volume":"3","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jac\/dkt358","article-title":"Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis","volume":"69","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B39","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1128\/AAC.00539-16","article-title":"Role of gyrB mutations in pre-extensively and extensively drug-resistant tuberculosis in Thai clinical isolates","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B40","year":"2012"},{"key":"key\n\t\t\t\t20170616061147_dkx110-B41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/JCM.02775-15","article-title":"Gyrase mutations are associated with variable levels of fluoroquinolone resistance in Mycobacterium tuberculosis","volume":"54","year":"2016","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/7\/1893\/17723552\/dkx110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T20:01:59Z","timestamp":1503604919000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkx110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,4,6]]},"published-print":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx110","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,6]]}}}